250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Health Care Startup Investors

A list of 50 angel investors and VC funds that invest in Health care startups. We rank investors based on the number of investments they made in Health care companies. This investor list updates every month.

Top 50 Health Care Startup Investors

Investor Health Care investments
Innova Memphis 132
Khosla Ventures 105
New Enterprise Associates 104
OrbiMed 102
ARCH Venture Partners 100
Right Side Capital Management 98
StartUp Health 98
F-Prime Capital 91
Rock Health Capital 85
Bpifrance 82
Connecticut Innovations 81
Versant Ventures 78
Alumni Ventures 74
Sofinnova Partners 70
Polaris Partners 69
Lux Capital 69
Novo Holdings 66
First Round Capital 66
Alexandria Venture Investments 65
BioAdvance 65
Atlas Venture 65
Founders Fund 64
Canaan Partners 64
General Catalyst 63
MPM Capital 62
Andreessen Horowitz 62
Gaingels 61
Global Founders Capital 61
High-Tech Grunderfonds 60
Third Rock Ventures 59
Portfolia 59
5AM Ventures 59
SV Angel 58
Enterprise Ireland 57
Novartis Venture Fund 56
Rev1 Ventures 53
Fifty Years 53
UK Innovation & Science Seed Fund 52
Wavemaker 360 51
M Ventures 51
Kurma Partners 50
Kleiner Perkins 50
HealthTech Capital 50
DCVC 50
Parkwalk Advisors 50
Google Ventures 50
Greycroft 49
Broadview Ventures 49
BoxGroup 49
Great Oaks Venture Capital 49
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Innova Memphis VC Fund · Memphis, Tennessee, United States · 10 investments in the past 12 months
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more
Investment focus
  • Health Care, Science/Engineering, Software
  • Seed, Pre-Seed, Series A
  • United States, Argentina, United Kingdom
Portfolio highlights
  • Glanris — Glanris developed a completely green, non-toxic, filtration media for water purification from an agriculture by-product. This agricultural product is grown around the world, is plentiful, and can be used locally to ensure clean drinking water in developing countries. It also gives local farmers a significant additional income source for a productthat today they are throwing away.This media has been independently tested over the last two years of development and is ready for production.
  • Isomark Health — Isomark Health is a patented AI-based, real-time and 100% green breath technology that detects and prevents bacterial and viral infections.
  • Stony Creek Colors — Stony Creek Colors is engaged in the production of bio-based dyes together with farmers, mills, and brands, in partnership with small farmers in the Southeast U.S. Stony Creek Colors was founded by Sarah Bellos in 2012 and is based in Tennessee, United States.
Khosla Ventures VC Fund · Menlo Park, California, United States · 57 investments in the past 12 months
Khosla Ventures is a venture capital firm started in 2004 by Vinod Khosla, Co-Founder of Sun Microsystems. The firm provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies.With over $15b assets under management, the firm focuses on a range of areas including consumer, enterprise, education,advertising, financial services, semiconductors, health, big data, agriculture, food, sustainable energy, and robotics. Khosla Ventures is headquartered in Menlo Park, California.
Show more
Investment focus
  • Software, Science/Engineering, Health Care
  • Series A, Series B, Seed
  • United States, India, United Kingdom
Portfolio highlights
  • Astrus — Astrus fully automates analog layout using AI without disrupting your workflow.
  • Sonocharge Energy — Sonocharge energy is developing a platform technology that enables a battery to charge. This technology energizes a range of markets such as transportation electric vehicles, e-mobility, electric bikes, scooters, aerospace, electric airplane, and drones.
  • Calimero Network — Calimero Network is a blockchain infrastructure that helps clients in controlling data. Calimero Network was founded in 2022 and was headquartered in London.
New Enterprise Associates VC Fund · Menlo Park, California, United States · 69 investments in the past 12 months
New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.
Show more
Investment focus
  • Software, Science/Engineering, Health Care
  • Series B, Series A, Series C
  • United States, India, China
Portfolio highlights
  • Brale — Combining the best of CeFi & DeFi.
  • Ledge — Ledge is a command center for payments built for finance teams operating at scale.Ledge empowers finance teams with tools to centralize their payments data, get a real-time payments snapshot, automate multi-way reconciliation, identify problem transactions, accelerate their investigations, and dramatically lower the risk of losses, all withoutany engineering support.Finance teams regain control of payments and are freed to focus on strategic business impact, not manual payments work.
  • Flox — Manage and share development environments, package your projects for others, and publish artifacts anywhere. Harness the power of Nix.
OrbiMed VC Fund · New York, New York, United States · 37 investments in the past 12 months
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series B, Series A, Series C
  • United States, China, Israel
Portfolio highlights
  • TandemAI — TandemAI is focused on lowering the barrier to entry to the most advanced tools in drug discovery.
  • BIOMx — Developing natural and engineered phage therapies to eradicate harmful bacteria in chronic diseases.
  • Garuda Therapeutics — Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.
ARCH Venture Partners VC Fund · Chicago, Illinois, United States · 30 investments in the past 12 months
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more
Investment focus
  • Science/Engineering, Biotechnology, Health Care
  • Series A, Series B, Series C
  • United States, China, Canada
Portfolio highlights
  • Paratus Sciences — Unlocking the secrets of bat biology. We are focused on elucidating novel insights and identifying new therapeutic targets.
  • Aera Therapeutics — Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of geneticmedicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.
  • IngredientWerks — IngredientWerks is a company operating in stealth. IngredientWerks was founded in 2022 and is based in Woburn, Massachusetts.
Right Side Capital Management VC Fund · San Francisco, California, United States · 6 investments in the past 12 months
Right Side Capital Management is a venture capital firm that helps startups build their company. It invests exclusively in the pre-seed round of technology startups and makes 75-100 investment per year. The firms prefers to invest in diversified technology sectors such as the internet and cloud companies.RSCM was established in 2010 and is basedin San Francisco, California.
Show more
Investment focus
  • Software, Data and Analytics, IT
  • Seed, Convertible Note, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • Benefitbay — Our ICHRA administration platform includes real-time plan modeling and a best-in-class premium payment solution. All backed by direct, human support.
  • Qeepsake — The easiest way to capture and preserve memories about your child or pregnancy.
  • LiveFreely — Track your health patterns in a modern way with BUDDY. BUDDY is an app that runs on your loved one's smartwatch. It tracks your all-day activities.
StartUp Health VC Fund · New York, New York, United States · 7 investments in the past 12 months
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more
Investment focus
  • Health Care, Software, Science/Engineering
  • Seed, Funding Round, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • eddii — eddii is virtual in app character designed to engage people living with diabetes to track and record their health.
  • Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
  • hav. — hav. is a rewards-based health-tech platform.
F-Prime Capital VC Fund · Cambridge, Massachusetts, United States · 33 investments in the past 12 months
We create and invest in healthcare and technology companies that improve lives all over the world.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series A, Series B, Series C
  • United States, United Kingdom, China
Portfolio highlights
  • NOCD — Reduce OCD severity significantly in just 10 weeks on average. Schedule a FREE phone call with team, and we'll connect you with a licensed OCD Therapist.
  • Enzene Biosciences — We are driven by the vision to positively impact the global healthcare landscape by delivering reliable and affordable medicines to improve life quality.
  • Paradigm — Paradigm is building a platform that enables equitable access to clinical trials while enhancing efficiency and improving ease of use for providers.
Rock Health Capital VC Fund · San Francisco, California, United States · 2 investments in the past 12 months
We invest in remarkable entrepreneurs working at the intersection of healthcare and technology.
Show more
Investment focus
  • Health Care, Software, IT
  • Seed, Series A, Series B
  • United States, Denmark
Portfolio highlights
  • Oula Health — Oula is modern maternity care that combines the best obstetrics and midwifery care in New York to deliver an evidence-based and personalized pregnancy experience in NYC.
  • WellTheory — Our programs support autoimmune lifestyle changes with an actionable and supportive membership experience, no matter where you are in your autoimmune journey.
  • Ribbon Health — Ribbon Health is building the infrastructure to transform healthcare decisions: with accurate and actionable provider information, including insurance coverage, prices, and performance.
Bpifrance VC Fund · Maisons-alfort, Ile-de-France, France · 95 investments in the past 12 months
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.
Show more
Investment focus
  • Software, Science/Engineering, Health Care
  • Funding Round, Seed, Series A
  • France, United States, Canada
Portfolio highlights
  • Locuta — Locuta specializes in callbots for call centers and commercial services.
  • NFL Biosciences — NFL Biosciences is a biotechnology company developing naturally based addiction withdrawal solutions. Its core product NFL-101, now in Phase II clinical trial aims to help smokers willing to quit win their battle for a healthier life.
  • Previa Medical — Previa Medical analyzes the data of the patients in real time and identifies the complication risks. They also provide forecasting pathology. They use FHIR technology for their solutions. The company's contact modes are by mail and physical address.
Connecticut Innovations VC Fund · Rocky Hill, Connecticut, United States · 15 investments in the past 12 months
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more
Investment focus
  • Health Care, Science/Engineering, Software
  • Seed, Series A, Funding Round
  • United States, Israel, Canada
Portfolio highlights
  • ReferWell — ReferWell leverages the referable moment to transform, simplify and integrate healthcare delivery so more people get the care they need.
  • Torigen Pharmaceuticals — Torigen is leading the pack in vet pharmaceuticals and oncology. Our tissue vaccine uses the tumor to create a personalized immunotherapy for treatment of cancer in both exotic and companion animals. We recognize the instrumental role animals play in society and our families, and are determined to
  • Bags — Grow your business with access to fair and flexible funding options designed to help you do your thing. Bags is the best place for business owners to get dollars for working capital, inventory, marketing, expansion, or anything else you need to grow.
Versant Ventures VC Fund · Menlo Park, California, United States · 7 investments in the past 12 months
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series A, Series B, Series C
  • United States, Switzerland, Canada
Portfolio highlights
  • Belharra Therapeutics — Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomicsplatform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.
  • Launchpad Therapeutics — Launchpad Therapeutics operates as an antibody-focused precision oncology company.
  • iECURE — Knocking down devastation. Inserting hope. At iECURE, we believe in vivo gene editing is the answer to meeting this immense patient need, and we believe reversing the course of these conditions is now within reach.
Alumni Ventures VC Fund · Manchester, New Hampshire, United States · 87 investments in the past 12 months
Alumni Ventures offers diversified venture portfolios to accredited investors into highly competitive deals that individuals typically do not have access to on their own.
Show more
Investment focus
  • Software, Science/Engineering, IT
  • Seed, Series A, Series B
  • United States, United Kingdom, Canada
Portfolio highlights
  • Crstl — Crstl
  • Vend Park — Unlock the true value of your parking asset with a fully digital parking access and revenue control system
  • Polybase — Polybase is web3 replacement for Firebase, Postgres and Supabase with native support for wallet-based permissions, token gating and zk proofs.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 13 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Science/Engineering, Biotechnology, Health Care
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Amolyt Pharma — We are building on our team's established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases.
  • EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
  • Microphyt — Discover exclusive biomimetic technology that unlocksthe full potential of untapped micro-algae diversity.
Polaris Partners VC Fund · Boston, Massachusetts, United States · 14 investments in the past 12 months
Polaris Partners ​has over 20-year history partnering with ​repeat entrepreneurs and innovators who are improving the way people live and work. The ​multibillion-dollar firm invests in healthcare and technology companies ​across all stages, from founding to profitable growth. ​Polaris has offices in Boston and San Francisco. ​Polaris Partners wasfounded in 1996 and is headquartered in Boston, Massachusetts.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series B, Series A, Series C
  • United States, Singapore, Ireland
Portfolio highlights
  • Paratus Sciences — Unlocking the secrets of bat biology. We are focused on elucidating novel insights and identifying new therapeutic targets.
  • August Bioservices — August Bioservices is a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services. August Bioservices provides comprehensive service offering to advance drug discovery, pharmaceutical development, and clinical manufacturing for the pharmaceutical and biotechnologyindustries. PMI BioPharma Solutions is uniquely positioned to support individual projects or to serve as an extension of its customers’ development teams. PMI BioPharma Solutions is planning to scale its manufacturing capabilities to support late-stage clinical and commercial liquid and lyophilized filling demand, to help support projects from clinical development to commercial launch.
  • Jnana Therapeutics — Jnana was founded by leading academic scientists, drug developers and investors to develop medicines that transform the lives of patients.
Lux Capital VC Fund · New York, New York, United States · 51 investments in the past 12 months
Lux Capital Management manages of $4 billion in assets focused on founding, seed, early-stage, and growth investments in the physical, material and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures our portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.
Show more
Investment focus
  • Software, Science/Engineering, Health Care
  • Series A, Seed, Series B
  • United States, Canada, United Kingdom
Portfolio highlights
  • Aera Therapeutics — Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of geneticmedicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.
  • Thatch — Thatch makes paying for healthcare easier and more modern. Our mission is to help businesses give great healthcare to their employees.
  • VulnCheck — Vulnerability intelligence that predicts avenues of attack with speed and accuracy.
Novo Holdings VC Fund · Hellerup, Hovedstaden, Denmark · 23 investments in the past 12 months
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom
Portfolio highlights
  • Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
  • Elo Life Systems — Elo is the Next Generation Ingredient Company. We unlock nature's abilities to make consumers' favorite foods more delicious, healthy and planet friendly.
  • LePure Biotech — Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples inbiosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.
First Round Capital VC Fund · San Francisco, California, United States · 35 investments in the past 12 months
First Round is a seed-stage venture firm focused on building a vibrant community of technology entrepreneurs and companies.
Show more
Investment focus
  • Software, Internet, IT
  • Seed, Series A, Series B
  • United States, Canada, India
Portfolio highlights
  • EvolutionIQ — Build a better insurance company with EvolutionIQ's claim guidance platform. Dramatically reduce reserves, losses, lower expenses and higher customer satisfaction, and are proven at Tier 1 carriers across Group Benefits & P&C. Founded by AI engineers from Google and Bloomberg.
  • Stelo Labs — Read the lastest on web3 security from Stelo
  • arketa — Online and in-person classes, video on-demand, courses and website hosting - all in one platform with arketa.
Alexandria Venture Investments VC Fund · Pasadena, California, United States · 24 investments in the past 12 months
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more
Investment focus
  • Science/Engineering, Biotechnology, Health Care
  • Series A, Series B, Series C
  • United States, France, Canada
Portfolio highlights
  • Paratus Sciences — Unlocking the secrets of bat biology. We are focused on elucidating novel insights and identifying new therapeutic targets.
  • Melonfrost — Melonfrost has created a novel way to optimize strains, eliminating the biggest bottleneck in the bioeconomy. By combining machine learning and evolution, our proprietary AI + Hardware platform steers the evolution of cells in real-time. Our algorithms explore the biological space and make decisions, while innovations in robotics, sensing, fluidicsand environmental control replace scientific labor, shaving years off the time to market for bioproducts. Evolution, from millenia to months.
  • Cajal Neuroscience — Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
BioAdvance VC Fund · Philadelphia, Pennsylvania, United States · 4 investments in the past 12 months
BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the Mid-Atlantic region.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Seed, Funding Round, Series A
  • United States, Canada
Portfolio highlights
  • Innervace — Innervace is a developer of a regenerative therapy company designed to develop implantable tissue-engineered brain pathways for neurodegenerative disorders.The company is focused on the development and commercialization of anatomically inspired living scaffolds for brain pathway reconstruction, and its lead clinical product is a tissue-engineerednigrostriatal pathway that mimics the lost nigrostriatal pathway in patients with Parkinson's disease. This gives patients access to technology that specifically reconstructs brain pathways rather than just masking symptoms temporarily.Innervace was established in 2018 by in Philadelphia, Pennsylvania
  • Senzo — Orphidia is developing a rapid blood diagnostic platform to simultaneously run common lab tests on a portable device.
  • Halo Labs — Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics.Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced ResearchProjects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.The company was founded in 2011 and headquartered in Pennsylvania, United States.
Atlas Venture VC Fund · Cambridge, Massachusetts, United States · 7 investments in the past 12 months
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.
Show more
Investment focus
  • Science/Engineering, Health Care, Biotechnology
  • Series A, Series B, Series C
  • United States, United Kingdom, Germany
Portfolio highlights
  • Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
  • Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
  • Disc Medicine — We are restoring regulation of hepcidin - the link between genetics and erythropoiesis - to create new therapies for patients with inherited and acquired anemias.
Founders Fund VC Fund · San Francisco, California, United States · 72 investments in the past 12 months
Founders Fund is a San Francisco based venture capital firm investing in companies building revolutionary technologies.
Show more
Investment focus
  • Software, Science/Engineering, Health Care
  • Series A, Seed, Series B
  • United States, United Kingdom, Germany
Portfolio highlights
  • Freeform — Freeform simplifies metal printing at any scale for all industries. Parts as a service to help you go from idea to production in days.
  • Chronosphere — Chronosphere is the only observability platform that puts you back in control by taming rampant data growth and cloud-native complexity, delivering increased business confidence.
  • SpaceX — SpaceX designs, manufactures and launches advanced rockets and spacecraft.
Canaan Partners VC Fund · Menlo Park, California, United States · 21 investments in the past 12 months
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more
Investment focus
  • Software, Science/Engineering, Health Care
  • Series A, Series B, Series C
  • United States, Israel, United Kingdom
Portfolio highlights
  • Grey Wolf Therapeutics — By targeting the ERAP proteases in the antigen presentation pathway Grey Wolf aims to change the neoantigen repertoire in cancer.
  • Komprise — Save on data storage costs with Komprise Intelligent Data Management, the leader in unstructured data management and cloud file data migration. Analyze. Mobilize.
  • Normunity — We create medicines that free normal immunity to defeat cancer using proprietary platforms that uncover novel immuno-oncology mechanisms.
General Catalyst VC Fund · Cambridge, Massachusetts, United States · 98 investments in the past 12 months
Investing in powerful, positive change that endures
Show more
Investment focus
  • Software, Internet, IT
  • Series A, Seed, Series B
  • United States, United Kingdom, India
Portfolio highlights
  • Finch — Finch is the API to access payroll and HR systems. We allow admins to connect their company in a compliant and secure manner to applications. Finch integrates across providers enabling developers to access a previously closed system and are at the source of truth for employee data and money flow. Our API powers use cases across lending, insurance,benefits, FP&A, and HR applications.
  • Puzzle — Puzzle is a Red Hat Certified Cloud Provider.
  • Chaos Labs — Chaos Labs is a fully automated on-chain economic security system that allows crypto protocols to optimize risk management and capital efficiency while safeguarding user funds. Chaos Labs offers a more secure and safe operating environment for crypto protocols. Chaos Labs uses technology and risk management expertise to help protocols navigate theoften volatile crypto markets and make informed decisions. The platform is currently available for protocols on the Ethereum network, with plans to expand to other blockchains such as Terra, NEAR, and Polygon in the future.
MPM Capital VC Fund · Cambridge, Massachusetts, United States · 4 investments in the past 12 months
Powering Breakthroughs in Life Sciences
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series B, Series A, Series C
  • United States, Canada, Germany
Portfolio highlights
  • NextPoint Therapeutics — NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.
  • Photys Therapeutics — Photys Therapeutics is a proprietary chimeric small molecules platform company, developing a new class of medicines for precise control of protein function.
  • Aktis Oncology — Aktis Oncology is a biotechnology company dedicated to realizing the curative power of alpha radiopharmaceuticals for the mainstream of cancer care
Andreessen Horowitz VC Fund · Menlo Park, California, United States · 179 investments in the past 12 months
Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, that backs bold entrepreneurs building the future through technology.
Show more
Investment focus
  • Software, Internet, Financial
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Shef — Enter code FIRST10 at checkout and save $10 on your first order
  • Zarta — Zarta is an ad free, micro pay per view video platform, and our mission is to connect creators directly to their community.
  • Skydio — Skydio Autonomous Drones for business, public safety and creative endeavors.
Gaingels VC Fund · New York, New York, United States · 127 investments in the past 12 months
Gaingels is a venture investment syndicate in support of and representing the LGBTQIA+ community and allies in the venture capital space. Gaingels also supports its companies with diverse talent and capital pipelines and provides an internal diverse board member recruitment advisory to help bring more diversity and representation within privateboards. Gaingels invests in companies with diverse/LGBTQIA+ founders and C-suite leaders at all stages of growth, as well as in other high-growth companies resolved on building more inclusive teams. Gaingels is an ardent supporter of the Diversity Term Sheet Rider Initiative to increase access to venture funding events for non-traditional check writers, and regularly co-invests with select VC leads across a variety of sectors, from technology to B2B, healthcare, and consumer, in competitive and over-subscribed rounds from Seed to Growth/pre-IPO. For more information visit www.gaingels.com.
Show more
Investment focus
  • Software, Health Care, Data and Analytics
  • Seed, Series A, Series B
  • United States, Canada, Israel
Portfolio highlights
  • HUSSLUP — Build an industry network. HUSSLUP enables creators in media and entertainment to build a diverse global community through personal profiles with verified credits and vouches and encrypted creative samples.
  • Get Spiffy — On-demand car cleaning technology and services company with the mission to redefine the car washing experience everywhere.
  • Bento — Create a beautiful page to show your audience everything you are, create, and sell in one link. Designed in Berlin.
Global Founders Capital VC Fund · Berlin, Berlin, Germany · 116 investments in the past 12 months
Over the past two decades, GFC have backed over five hundred entrepreneurs worldwide, e.g. Facebook, LinkedIn, Slack, and Away Travel.
Show more
Investment focus
  • Software, Financial, Commerce/Shopping
  • Seed, Series A, Pre-Seed
  • United States, Germany, United Kingdom
Portfolio highlights
  • Transcend Therapeutics — Transcend Therapeutics is a biotechnology company discovering, developing and delivering the next generation of psychoactive compounds focused on patient access to create a world where people no longer suffer with neuropsychiatric disease.
  • Tranch — Tranch brings payment flexibility to B2B by offering expense financing services for fast-growing businesses. With Tranch, businesses can spread bulky expenses and take control of the cash flow on their terms and prioritise spend on growth, without compromising on the tools they need. Tranch transforms how businesses pay with Grow Now, Pay Later.
  • Keyzy — Keyzy's mission is to unlock home ownership in the UK. Our rent-to-own solution turns home ownership from a dream into a reality.
High-Tech Grunderfonds VC Fund · Bonn, Nordrhein-Westfalen, Germany · 45 investments in the past 12 months
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.
Show more
Investment focus
  • Software, Science/Engineering, Health Care
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • hbox — We are developing therapies based on the principle of minimally invasive targeted hyperoxygenation.
  • Sdui — Sdui is the solution for mobile communication in schools. With amazingly easy features for messaging, timetables and a wide range of third party integrations, the app digitizes processes and reduces administrative effort. Within two years, Sdui has reached hundreds of institutions and grown a serious reputation in the educational market.
  • Maya Climate — Accelerating investments in early-stage nature-based carbon projects, by connecting project developers with commercial investors on a single platform that digitizes project origination, risk assessment and due diligence.
Third Rock Ventures VC Fund · Boston, Massachusetts, United States · 5 investments in the past 12 months
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients.
Show more
Investment focus
  • Health Care, Biotechnology, Science/Engineering
  • Series A, Series B, Series C
  • United States
Portfolio highlights
  • CARGO Therapeutics — CARGO Therapeutics develops CAR T-cell therapy to overcome cancer treatment resistance and address access barriers so that more patients can benefit from potentially curative therapies. The company is on a mission to outwit cancer by developing best-in-class chimeric antigen receptor (CAR) T-cell therapies. Despite commercially available autologousCARs advancements, these treatments are curative for less than half of all cancer patients. Furthermore, far too many patients are unable to access these potentially curative therapies due to other obstacles such as manufacturing, supply constraints, long turnaround times, and reimbursement barriers. CARGO's team is intensely focused on pursuing novel solutions to improve cancer treatment outcomes and experiences.
  • Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
  • Terremoto Biosciences — By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.
Portfolia VC Fund · San Mateo, California, United States · 16 investments in the past 12 months
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more
Investment focus
  • Health Care, Software, Science/Engineering
  • Seed, Series A, Series B
  • United States, Canada, Argentina
Portfolio highlights
  • Nalu Bio — Nalu Bio is the leading innovator in the discovery and production of next generation cannabinoid ingredients.
  • Kanarys — Kanarys fuels progress towards more diverse, equitable and inclusive workplace cultures
  • Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
5AM Ventures VC Fund · Menlo Park, California, United States · 6 investments in the past 12 months
5AM Ventures is a venture capital firm that offers seed- and early-stage investments to its clients. The company’s client portfolio consists of firms in the biopharmaceutical, life sciences, medical technology, and research instrument industries. 5AM Ventures was founded in 2002 by John Diekman and Andrew Schwab and is based in California.
Show more
Investment focus
  • Science/Engineering, Biotechnology, Health Care
  • Series A, Series B, Series C
  • United States, Switzerland, Canada
Portfolio highlights
  • Novome Biotechnologies — Novome Biotechnologies, Inc. is a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The Company has developed the first-ever platform for controlled colonization of the gut with engineered bacteria, enabling first-in-class living therapeutics: Genetically Engineered MicrobialMedicines (GEMMs). Novome is utilizing its proprietary GEMMs platform in its lead preclinical program in hyperoxaluria, which is focused on the development of a therapeutic strain of bacteria that degrades oxalate to prevent the formation of kidney stones. Efforts are also directed to the expansion of its proprietary synthetic biology platform into additional indications.
  • Disc Medicine — We are restoring regulation of hepcidin - the link between genetics and erythropoiesis - to create new therapies for patients with inherited and acquired anemias.
  • CAMP4 Therapeutics — CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start todisease treatment, significantly reducing the time and risk to bring new medicines to patients.
SV Angel VC Fund · San Francisco, California, United States · 48 investments in the past 12 months
SV Angel is a San Francisco-based seed fund founded by Ron Conway. SV Angel provides seed investment and advice to early stage companies focused on Internet software.SV Angel takes a portfolio approach to seed investing. We differ from a traditional venture capital firm by not taking board seats and investing a larger number of companies. Weleverage a best in class relationship network to be the valley's human router and help startups with business development, financing, M&A and other strategic advice. Ron pioneered this approach over 20 years ago and SV Angel still employs it today. Over the last 25 years the firm and partners have invested and advised companies such as Facebook, Google, PayPal, Dropbox, Airbnb, Pinterest, Twitter, SnapChat, Square, Cloudera and many more.
Show more
Investment focus
  • Software, Internet, IT
  • Seed, Series A, Series B
  • United States, United Kingdom, Canada
Portfolio highlights
  • Cycle App — Cycle is a horizontal platform made of flexible building blocks that you can use in customizable workflows. Your way of working shouldn't depend on your tools, they built Cycle so that product teams could ship the way that works for them.
  • Method Financial — Method makes it easy for developers to embed debt repayment on their apps.
  • Architect — Architect gives traders customizable infrastructure that reimagines access to international markets for digital assets. Building institutional-grade infrastructure to link different crypto venues across centralized and decentralized exchanges is one of the project's goals.
Enterprise Ireland VC Fund · Dublin, Dublin, Ireland · 26 investments in the past 12 months
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more
Investment focus
  • Software, Health Care, IT
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Imvizar — Imvizar focuses on life-size, location-based experiences that allow users to feel as if they've gone back in time, meeting renowned individuals and witnessing historical events all from the comfort of their own phone. Imvizar was founded by Michael Guerin and is located in Dublin, Ireland.
  • Teleatherapy — Teleatherapy delivers speech therapy from home for parkinson's disease.
  • Proveye — We are pioneering the potential of digital imagery for more predictable and profitable decision-making for agriculture and the environment.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 2 investments in the past 12 months
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Capstan Therapeutics — Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
  • Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Rev1 Ventures VC Fund · Columbus, Ohio, United States · 7 investments in the past 12 months
Rev1 Ventures provides seed stage venture capital funding in Columbus, Ohio along with startup services, space, mentoring, and connections. Learn more!
Show more
Investment focus
  • Software, Health Care, Science/Engineering
  • Seed, Series A, Funding Round
  • United States, Germany
Portfolio highlights
  • Clarametyx Biosciences — Clarametyx Biosciences is a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms.
  • Synota — Synchronizing data and payments with the flow of energy.
  • Upshift — Looking for temp staffing solutions for your business? Find pre-screened W2 workers for hourly staffing needs through our mobile app. Learn More to Save More.
Fifty Years VC Fund · San Francisco, California, United States · 15 investments in the past 12 months
WE BACK HEROES using technology to solve the world's biggest problems
Show more
Investment focus
  • Science/Engineering, Health Care, Biotechnology
  • Seed, Series A, Series B
  • United States, Germany, Canada
Portfolio highlights
  • Journey Clinical — Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care.
  • UTVATE — Unlocking satellite internet capacity through user terminal innovation
  • BillionToOne — We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
UK Innovation & Science Seed Fund VC Fund · Harwell, Oxfordshire, United Kingdom · 7 investments in the past 12 months
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more
Investment focus
  • Science/Engineering, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • Vector Photonics — Vector Photonics is a spin-out company from the University of Glasgow and is based in Glasgow, Scotland, one of the UK and world’s Optical and Photonics centres of excellence.
  • MicrofluidX — Delivering the next generation of automated cell and gene therapy manufacturing platforms to bring precision medicine to patients
  • Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Wavemaker 360 VC Fund · Pasadena, California, United States · 6 investments in the past 12 months
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more
Investment focus
  • Health Care, Software, Science/Engineering
  • Seed, Series A, Funding Round
  • United States, Canada, United Kingdom
Portfolio highlights
  • UptimeHealth — UptimeHealth, headquartered in Boston, MA, is a fast-growing software startup that simplifies medical device service events, purchases, and compliance practices through automation and predictive analytics.
  • Advocatia Solutions — Advocatia simplifies how uninsured patients identify financial assistance programs and enroll into coverage.
  • Skin Analytics — Skin Analytics provides AI-supported teledermatology services to support clinicians in the assessment of skin lesions
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 9 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Science/Engineering, Health Care, Biotechnology
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
  • Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
  • Sonde Health — Sonde Health is a digital medicine company developing voice-based technologies to transform the way we monitor and diagnose our mental and physical health.
Kurma Partners VC Fund · Paris, Ile-de-France, France · 4 investments in the past 12 months
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series A, Seed, Series B
  • France, Spain, Switzerland
Portfolio highlights
  • Ganymed Robotics — Ganymed Robotics, a new vision of orthopedic surgery. We develop advanced AI and robotics technologies for orthopedics.
  • Charles.co — Charles helps men regain control over their daily health concerns by starting with their personal health. The company was founded in Paris, Ile-de-France, France in 2019.
  • ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
Kleiner Perkins VC Fund · Menlo Park, California, United States · 37 investments in the past 12 months
Kleiner Perkins is an American venture capital firm headquartered on Sand Hill Road in Menlo Park in Silicon Valley.
Show more
Investment focus
  • Software, IT, Internet
  • Series B, Series A, Series C
  • United States, China, United Kingdom
Portfolio highlights
  • Simple HealthKit — Simple HealthKit (SHK) is healthcare from anywhere. Re-built for everyone. We build affordable, accessible and accurate end-to-end diagnostic and digital health solutions.
  • Vylo — Vylo is thoughts and conversations about news that interests you.
  • Bakool — Bakool is an app for online food delivery.
HealthTech Capital VC Fund · Los Altos Hills, California, United States · 8 investments in the past 12 months
Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups
Show more
Investment focus
  • Health Care, Software, Science/Engineering
  • Seed, Series A, Convertible Note
  • United States
Portfolio highlights
  • GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
  • Junum — Improve patient outcomes through clinical nutrition.
  • Agile Therapeutics — Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and Ethinylestradiol. The company was founded in 1997 as Levotech, Inc. and changed its name toAgile Therapeutics, Inc. in April 2001. It is based in Princeton, New Jersey.
DCVC VC Fund · San Francisco, California, United States · 23 investments in the past 12 months
Deep Tech VC firm with over $3B under management
Show more
Investment focus
  • Software, Science/Engineering, Data and Analytics
  • Seed, Series A, Series B
  • United States, Canada, Australia
Portfolio highlights
  • Aquafortus — Aquafortus specializes in providing enviornmental services and commercializes proprietary zero liquid discharge technology.
  • Nest Genomics (YC W22) — Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.
  • Reach — Founded out of MIT, Reach Labs is deeply rooted in technology and design. Their mission is to empower the world with seamless connectivity.
Parkwalk Advisors VC Fund · London, England, United Kingdom · 17 investments in the past 12 months
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more
Investment focus
  • Science/Engineering, Health Care, Software
  • Seed, Series A, Series B
  • United Kingdom, United States, Philippines
Portfolio highlights
  • Quantum Motion — One Hundred Qubits is Interesting. One Million is World-changing
  • Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team
  • Diffblue — Diffblue helps accelerate your shift left by automatically writing suites of unit regression tests so you can catch errors faster and earlier in your pipeline
Google Ventures VC Fund · Mountain View, California, United States · 75 investments in the past 12 months
GV supports innovative founders moving the world forward.
Show more
Investment focus
  • Software, Science/Engineering, Health Care
  • Series B, Series A, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Chroma Medicine — Chroma Medicine is pioneering a new class of epigenetic medicines to revolutionize treatment of genetically driven disease.
  • Typeface — Typeface, the generative AI application for enterprise content creation, empowers all businesses to create exceptional, on-brand content at supercharged speeds.
  • Aera Therapeutics — Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of geneticmedicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.
Greycroft VC Fund · New York, New York, United States · 44 investments in the past 12 months
Venture capital and technology investments
Show more
Investment focus
  • Software, Media and Entertainment, Internet
  • Series A, Seed, Series B
  • United States, United Kingdom, Germany
Portfolio highlights
  • Stakeholder Labs — Stakeholder Labs builds enterprise software to help companies measure and increase retail investor engagement. Its flagship product, Roundtable, enables companies to verify shareholders, measure their customer loyalty and offer unique shareholder rewards. To learn more about Stakeholder Labs, please visit stakeholderlabs.com.
  • Craft.co — Craft is a machine-learning powered data and analytics platform building the “Source of Truth” on companies and mapping the global economy. The company organizes financial, operating and human capital data from thousands of sources to provide comprehensive, up-to-date sector and company profiles, ranging from early-stage to the largest companies inthe world, with analytics and tools such as signal alerts, trends and benchmarking.
  • Howdy — Howdy takes a human-centered approach to finding top software engineering talent in Latin America and pairing them with innovative U.S. tech employers. Howdy takes care of talent sourcing, payroll, local HR benefits, equipment, and ongoing mentorship to help tech companies build strong long-term engineering teams and foster the engineeringcommunity in LATAM.Formerly known as Austin Software, Howdy is headquartered in Austin, TX, and has six local offices in Montevideo, Buenos Aires, Bogota, Medellin, Cordoba, and Santiago. The company raised a $13M Series A funding round in August 2022 led by Greycroft.
Broadview Ventures VC Fund · Boston, Massachusetts, United States · 4 investments in the past 12 months
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more
Investment focus
  • Health Care, Science/Engineering, Biotechnology
  • Series A, Seed, Debt Financing
  • United States, Israel, Denmark
Portfolio highlights
  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
BoxGroup VC Fund · New York, New York, United States · 58 investments in the past 12 months
BoxGroup is an early stage investment fund focused on technology companies. Contact Us: hello@boxgroup.com
Show more
Investment focus
  • Software, Internet, Financial
  • Seed, Series A, Series B
  • United States, Canada, France
Portfolio highlights
  • Cycle App — Cycle is a horizontal platform made of flexible building blocks that you can use in customizable workflows. Your way of working shouldn't depend on your tools, they built Cycle so that product teams could ship the way that works for them.
  • Stelo Labs — Read the lastest on web3 security from Stelo
  • Macro — Macro - The next-gen, free-to-use, productivity suite.
Great Oaks Venture Capital VC Fund · New York, New York, United States · 21 investments in the past 12 months
Great Oaks is an early-stage venture investment firm that invests in seed and series a investments in tech-based startups. It was founded in 2005 and is headquartered in New York.
Show more
Investment focus
  • Software, Commerce/Shopping, Internet
  • Seed, Series A, Series B
  • United States, United Kingdom, Spain
Portfolio highlights
  • Passthrough — Save time and frustration with a seamless online experience that makes it easy to invest in private funds.
  • Kinspire — Kinspire Health | Child Occupational Therapy
  • Oula Health — Oula is modern maternity care that combines the best obstetrics and midwifery care in New York to deliver an evidence-based and personalized pregnancy experience in NYC.
Investors by industry
Investors by country
Investors in Health Care by country
Angel investors in Health Care by country
VC Funds in Health Care by country